Pharmaceutical
Found 70 companies.
๐Ÿข Vetcove
๐Ÿ‘ฅ 101-250๐Ÿ’ฐ $3,025,000 Pre-seed over 8 years agoPharmaceuticalMarketplaceSupply Chain ManagementVeterinaryHealth CareHealth Diagnostics๐Ÿ’ผ Private Company
Website LinkedIn Email Facebook Twitter

Vetcove is revolutionizing the veterinary supply chain, acting as the Kayak.com of veterinary hospitals. We provide a comprehensive marketplace where veterinary practices can compare prices, check stock, and order supplies from over 200,000 SKUs and 2,100 manufacturers in one unified platform. Our platform provides a centralized catalog, insightful data, and special pricing visibility, empowering veterinary teams to operate more profitably and focus on pet care. We leverage a modern tech stack to deliver our services, including technologies like iPhone / Mobile Compatibility, Google Tag Manager, and Google Analytics, all backed by robust security protocols like SSL and HSTS. Our commitment to a secure and reliable platform is reflected in our default security measures. At Vetcove, we foster a collaborative, remote-first culture, with a team of 101-250 employees spread across the United States. As a Y Combinator-backed company, we're experiencing significant growth and are backed by notable investors in Silicon Valley and NYC. Our mission is to modernize the $50B+ animal health industry, making it easier for veterinary practices to thrive. We are looking for exceptionally talented and passionate people to join our growing team. With benefits like 100% remote work, medical, dental, and vision insurance, and open vacation policies, we're committed to creating a supportive and rewarding work environment. We also offer competitive compensation packages, including equity. If you're a sharp, driven individual looking to make a direct impact on the future of animal health, Vetcove is the place for you!

๐Ÿข Impiricus
๐Ÿ‘ฅ 11-50๐Ÿ’ฐ $3,000,000 Seed almost 3 years agoPharmaceuticalMedicalHealth Care๐Ÿ’ผ Private Company
Website LinkedIn Email Facebook Twitter

Impiricus is revolutionizing healthcare professional (HCP) engagement by connecting them with the resources they need to improve patient outcomes. We've built a digital platform that streamlines communication between HCPs and life science companies, delivering evidence-based information and resources directly to the point of care. Our innovative approach, guided by a council of physician advisors, ensures that every message we deliver supports better patient care. Our technology stack includes WordPress, Google Analytics, Google Tag Manager, and other modern tools to deliver a seamless user experience and robust data analysis. We're committed to staying at the forefront of technological innovation to provide the best possible experience for both HCPs and our partners in the device and digital therapeutics space. We value a culture of learning and collaboration. Impiricus fosters an environment where team members can expand their skills and expertise and maximize their potential, with full support and career development opportunities. Founded in 2021, Impiricus is experiencing significant growth and has already secured seed funding to fuel our expansion. We're a remote-friendly company, offering a collaborative and inclusive environment where team members are empowered to bring ideas to the table and act. We offer a comprehensive benefits package, including comprehensive healthcare, unlimited PTO, and 401K matching. Join us to make a real difference in the healthcare industry, build innovative solutions, and be part of a company that values both individual and team success.

๐Ÿข Acadia Pharmaceuticals Inc.
๐Ÿ‘ฅ 501-1000๐Ÿ’ฐ $287,500,000 Post-IPO Equity over 5 years agoPharmaceuticalBiotechnologyHealth Care๐Ÿ“ˆ Public Company
Website LinkedIn Email Facebook Twitter

Acadia Pharmaceuticals Inc. is a biopharmaceutical company at the forefront of developing and commercializing innovative small molecule drugs for central nervous system (CNS) disorders. We currently focus on our lead product, pimavanserin, which is approved for treating hallucinations and delusions associated with Parkinson's disease psychosis and for Rett syndrome. Our unique value proposition lies in our commitment to addressing unmet medical needs in the neuroscience space, fostering a collaborative environment for groundbreaking research, and bringing critical solutions to patients. Our technology stack supports our research and development, clinical trials, and commercial operations. We utilize advanced technologies including SPF, SSL by Default, DNSSEC, and Cloudflare CDN to ensure the security and reliability of our digital infrastructure. Our remote-first approach helps us support our global presence, including our wholly owned subsidiaries in Sweden and Denmark. Acadia boasts a dynamic and driven culture, with a commitment to innovation and patient impact. Our team of 501-1000 employees works collaboratively to push the boundaries of neuroscience. We are a publicly traded company (NASDAQ:ACAD) with significant funding, allowing us to invest heavily in research and development, and expand our late-stage pipeline targeting neuro-psychiatric and neuro-rare diseases. We are committed to attracting, retaining, and developing talented people from diverse backgrounds. We are currently experiencing a period of significant growth, with several product candidates in the development pipeline, including therapies for Prader-Willi syndrome and Alzheimer's disease psychosis. This rapid expansion presents numerous exciting career opportunities for talented individuals looking to make a difference in the lives of patients.

๐Ÿข Super Speciosa
๐Ÿ‘ฅ 11-50PharmaceuticalConsumer GoodsHealth Care๐Ÿ’ผ Private Company
Website LinkedIn Email Facebook Twitter

Super Speciosa is a leading direct-to-consumer brand providing high-quality, lab-tested kratom products. Since 2016, we've built a reputation for safety, transparency, and quality, becoming a trusted leader in the kratom industry. Our tech stack supports our e-commerce platform, utilizing technologies like Google Analytics, Google Tag Manager, and a content delivery network to ensure a smooth customer experience. We're also mobile-first, with a focus on responsive design and user experience. Our commitment to research is demonstrated by our participation in FDA-contracted clinical trials. We leverage social media and community platforms to connect with our customers and foster a strong brand community. We are a collaborative, high-energy environment where professionals can grow. With a team size of 11-50 employees, we offer exciting opportunities for remote work. If you're passionate about the kratom industry and ready to contribute to a dynamic and growing company, we encourage you to apply.

๐Ÿข Zenas BioPharma
๐Ÿ‘ฅ 51-100๐Ÿ’ฐ $200,000,000 Series C 11 months agoPharmaceuticalBiopharmaHealth Care๐Ÿ“ˆ Public Company
Website LinkedIn

Zenas BioPharma is a rapidly growing biopharmaceutical company focused on developing and commercializing innovative immune-based therapies for autoimmune and rare diseases. We're making a significant impact in the industry by advancing a robust pipeline of first- and best-in-class therapeutics addressing critical unmet medical needs. Our commitment to scientific rigor and patient well-being drives our work. Our technology stack includes a blend of leading-edge tools and platforms, leveraging WordPress for our website, Google Analytics and Google Tag Manager for data analysis, and a Content Delivery Network for optimal performance. We embrace a collaborative and efficient work environment, fostering innovation and rapid progress towards our therapeutic goals. While our headquarters are in Waltham, MA, we offer numerous remote opportunities, allowing us to attract top talent globally. At Zenas, we are driven by our values of Transparency, Relationships, Urgency, Excellence, and Innovation. This commitment to excellence translates into a supportive and inclusive culture, where employees are empowered to contribute their unique skills and perspectives. We offer a competitive compensation and benefits package, along with opportunities for professional growth and development. Backed by significant Series C funding and recently completed a successful IPO, Zenas BioPharma is experiencing rapid growth and is poised to become a leader in the immunology and autoimmune disease space. We invite you to join our team and contribute to our mission of improving the lives of patients worldwide.

๐Ÿข Disc Medicine
๐Ÿ‘ฅ 51-100๐Ÿ’ฐ $225,500,000 Post-IPO Equity 2 months agoPharmaceuticalBiotechnologyTherapeuticsMedicalHealth Care๐Ÿ“ˆ Public Company
Website LinkedIn Email Twitter

Disc Medicine is a clinical-stage biopharmaceutical company at the forefront of hematologic disease treatment. We are dedicated to discovering, developing, and commercializing novel therapies for patients with severe hematologic disorders, with our pipeline focused on innovative treatments like bitopertin. Our commitment lies in targeting fundamental biological pathways and developing first-in-class therapeutic candidates. Our tech stack supports our mission with platforms like Drupal, Akamai EdgeWorkers, and Adobe Dynamic Tag Management. We leverage technologies like HSTS, Google Maps, and mobile optimization to ensure our digital infrastructure is robust and accessible. Our engineering culture is collaborative, and we value scientific integrity. We are growing rapidly and committed to technological innovation to advance our research and development efforts. We are a publicly traded company with strong financial backing and a focus on attracting talented professionals. We offer a hybrid work environment, and our Watertown, MA, headquarters provides a collaborative setting. At Disc Medicine, we foster an inclusive company culture that promotes professional development and empowers our employees. We're seeking individuals with an entrepreneurial spirit and a drive for excellence to join our team and help us make a difference in patients' lives.

๐Ÿข Cresco Labs
๐Ÿ‘ฅ 1001-5000๐Ÿ’ฐ $125,000,000 Post-IPO Equity about 4 years ago๐Ÿซ‚ Last layoff about 2 years agoPharmaceuticalCannabisMedicalHealth Care๐Ÿ“ˆ Public Company
Website LinkedIn Email Facebook Twitter

Cresco Labs is a leading, publicly traded, vertically integrated multi-state cannabis operator revolutionizing the medical cannabis industry. We cultivate, manufacture, and distribute high-quality cannabis products through our consumer-packaged-goods (CPG) approach. Our brand portfolio includes some of the most popular and award-winning cannabis products in the U.S., reaching consumers through our network of Sunnysideยฎ dispensaries. We're committed to normalizing and professionalizing the cannabis industry, fostering a culture of compliance and quality. Our technology stack leverages cloud infrastructure (Google Cloud), robust security measures (HSTS, DNSSEC), and content delivery networks (Cloudflare CDN) to support our nationwide operations. While our engineering culture is not explicitly detailed, our reliance on these key technologies suggests a modern, scalable, and reliable tech infrastructure. Our emphasis on data-driven decision making is clearly evident in roles like the Sr. Analyst, Retail Data position. Our commitment to innovation and data analytics is central to our growth strategy. At Cresco Labs, we're driven by a mission to normalize, professionalize, and revolutionize cannabis. We champion social equity and educational development through our SEEDโ„ข initiative, ensuring equal opportunity across our workforce and the communities we serve. We prioritize regulatory compliance and product consistency, upholding the highest level of integrity and professionalism in all our endeavors. With a substantial employee base (1001-5000), significant funding, and a strong public market presence, Cresco Labs offers a dynamic and rapidly growing career environment for professionals seeking to contribute to a progressive industry. We are constantly expanding and evolving to lead the future of cannabis.

๐Ÿข Kalderos
๐Ÿ‘ฅ 51-100๐Ÿ’ฐ $14,929,980 over 2 years agoPharmaceuticalSaaSHealth Care๐Ÿ’ผ Private Company
Website LinkedIn Email Twitter

Kalderos is a forward-looking company that is currently evaluating future talent and opportunities. While specific technologies and employee information are not disclosed, they welcome interest from potential candidates for upcoming positions.

๐Ÿข Corcept Therapeutics
๐Ÿ‘ฅ 251-500๐Ÿ’ฐ $525,305 Post-IPO Equity almost 13 years agoPharmaceuticalBiotechnologyMedical๐Ÿ“ˆ Public Company
Website LinkedIn Email Twitter

Corcept Therapeutics: Pioneering Cortisol Modulation for Serious Diseases Corcept Therapeutics is a publicly traded biopharmaceutical company focused on developing and commercializing drugs that regulate the effects of cortisol, a hormone impacting nearly 80% of the body's tissues. Our flagship product, Korlymยฎ (mifepristone), is an FDA-approved treatment for hypercortisolism (Cushing's syndrome). We are currently expanding into oncology with a robust pipeline of investigational drugs targeting various serious diseases. We leverage a modern technology stack, including Amazon Web Services, Cloudflare CDN and Hosting, and various security technologies (DNSSEC, HSTS, reCAPTCHA) to ensure efficient operations and robust data security. Our engineering team utilizes technologies such as jQuery, while maintaining a commitment to innovation and collaboration. We offer a diverse range of opportunities across various departments, including marketing, sales, and clinical development, with several roles offering remote work options. Corcept fosters a culture of scientific excellence and patient-centricity. We value innovation, collaboration, and a dedication to improving the lives of those suffering from serious diseases. We are committed to advancing the possibilities of cortisol modulation as a therapeutic approach, and this is reflected in our extensive research and development efforts โ€“ boasting over 30 ongoing studies across several disease areas. Our dedication to expanding our knowledge in this field and advancing innovative solutions makes Corcept an exciting place to work. With a team of 251-500 employees and a history dating back to 1998, Corcept continues to grow, driven by both a strong intellectual property portfolio and a commitment to bringing life-changing medications to patients. Our recent expansion into oncology represents a major step in our growth trajectory.

๐Ÿข Clinigen
๐Ÿ‘ฅ 251-500PharmaceuticalIndustrialManufacturing๐Ÿ’ผ Private Company
Website LinkedIn Email

Clinigen is a global specialty pharmaceutical and services company focused on delivering vital medicines worldwide. We operate within a complex regulatory landscape, ensuring timely and secure access to essential medications for patients. Our services span managed access programs, pharmaceutical manufacturing, and consulting. Clinigen's unique combination of businesses positions us as a leader in our field, and we're consistently innovating to address evolving market needs and improve patient outcomes. We currently employ over 1100 people across the globe. Our technology stack supports a range of functions, including analytics with Hotjar and secure hosting through Irish server infrastructure. We're committed to leveraging data effectively and integrating technological solutions to improve our processes and services. We value a collaborative and supportive work environment. Our current job postings highlight exciting opportunities in various departments and locations, reflecting our global reach. Clinigen has experienced rapid growth since its founding in 2010 and maintains a strong presence in the UK, US, EU, JAPAC, and South Africa. We offer competitive salaries and benefits packages, including opportunities for professional development and career growth within a fast-paced and dynamic company culture. Weโ€™re proud of our achievements, including successful acquisitions that bolster our capabilities and expand our service offerings. Our commitment to innovation and patient-centric care continues to drive our success and propel our ambitious growth strategy.

Shown 10 out of 70